McMullin, M. F., Ghebretinsea, F., Boucher, R., Francis, S., Horne, G., Hussein, H., Knapper, S., McLornan, D., Narayanan, S., Sullivan, J. O., Somervaille, T., Teh, C., Wadelin, F., Sankhalpara, C., Yafai, E., Thomas, C., Hargreaves, R., Hayder, N., Mcllroy, G., Harrison, C., Mead, A. (2025). Fedora preliminary analysis of a Phase II study evaluating the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis.. Blood. https://doi.org/10.1182/blood-2025-486